The global market for Co-immunoprecipitation (Co-IP) Service was valued at US$ 477 million in the year 2024 and is projected to reach a revised size of US$ 676 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Co-immunoprecipitation (Co-IP) Service Market

Co-immunoprecipitation (Co-IP) service is a method for studying protein interactions based on the interaction between antibodies and antigens. The principle is to use endogenous target proteins in cells as bait, co incubate target protein antibodies with total cell proteins, and promote the formation of immune complexes. Subsequently, protein A/G that can bind to the target protein antibody is added to form a "binding protein target protein target protein antibody" complex. After purification, the immune complex is separated by gel electrophoresis, combined with Western blot or mass spectrometry technology, so as to purify the target protein and qualitatively detect antigen or antibody.

North American market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Co-immunoprecipitation (Co-IP) Service in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Co-immunoprecipitation (Co-IP) Service include Creative Proteomics, Lifeasible, ThermoFisher Scientific, Profacgen, Creative BioMart, Biologics International Corp, Creative Diagnostics, CD BioSciences, Beijing Abace Biology, Nanjing Detai Bioengineering, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Co-immunoprecipitation (Co-IP) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Co-immunoprecipitation (Co-IP) Service.

The Co-immunoprecipitation (Co-IP) Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Co-immunoprecipitation (Co-IP) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Co-immunoprecipitation (Co-IP) Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Co-immunoprecipitation (Co-IP) Service Market Report

Report Metric	Details
Report Name	Co-immunoprecipitation (Co-IP) Service Market
Accounted market size in year	US$ 477 million
Forecasted market size in 2031	US$ 676 million
CAGR	5.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tag Protein Immunoprecipitation Non Tagged Protein Immunoprecipitation Chromatin Immunoprecipitation
Segment by Application	Drug Development Biomedical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Creative Proteomics, Lifeasible, ThermoFisher Scientific, Profacgen, Creative BioMart, Biologics International Corp, Creative Diagnostics, CD BioSciences, Beijing Abace Biology, Nanjing Detai Bioengineering, Guangzhou Fitgene Biotechnology, Nanjing Zoonbio Biotechnology, Shanghai Beyotime Biotechnology, Beijing Bio-Tech Pack Scientific, Wuhan Genecreate, Wuhan Biorun BioSciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Co-immunoprecipitation (Co-IP) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Co-immunoprecipitation (Co-IP) Service Market growing?

Ans: The Co-immunoprecipitation (Co-IP) Service Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Co-immunoprecipitation (Co-IP) Service Market size in 2031?

Ans: The Co-immunoprecipitation (Co-IP) Service Market size in 2031 will be US$ 676 million.

Who are the main players in the Co-immunoprecipitation (Co-IP) Service Market report?

Ans: The main players in the Co-immunoprecipitation (Co-IP) Service Market are Creative Proteomics, Lifeasible, ThermoFisher Scientific, Profacgen, Creative BioMart, Biologics International Corp, Creative Diagnostics, CD BioSciences, Beijing Abace Biology, Nanjing Detai Bioengineering, Guangzhou Fitgene Biotechnology, Nanjing Zoonbio Biotechnology, Shanghai Beyotime Biotechnology, Beijing Bio-Tech Pack Scientific, Wuhan Genecreate, Wuhan Biorun BioSciences

What are the Application segmentation covered in the Co-immunoprecipitation (Co-IP) Service Market report?

Ans: The Applications covered in the Co-immunoprecipitation (Co-IP) Service Market report are Drug Development, Biomedical Research

What are the Type segmentation covered in the Co-immunoprecipitation (Co-IP) Service Market report?

Ans: The Types covered in the Co-immunoprecipitation (Co-IP) Service Market report are Tag Protein Immunoprecipitation, Non Tagged Protein Immunoprecipitation, Chromatin Immunoprecipitation

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tag Protein Immunoprecipitation

1.2.3 Non Tagged Protein Immunoprecipitation

1.2.4 Chromatin Immunoprecipitation

1.3 Market by Application

1.3.1 Global Co-immunoprecipitation (Co-IP) Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Drug Development

1.3.3 Biomedical Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Co-immunoprecipitation (Co-IP) Service Market Perspective (2020-2031)

2.2 Global Co-immunoprecipitation (Co-IP) Service Growth Trends by Region

2.2.1 Global Co-immunoprecipitation (Co-IP) Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Co-immunoprecipitation (Co-IP) Service Historic Market Size by Region (2020-2025)

2.2.3 Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Region (2026-2031)

2.3 Co-immunoprecipitation (Co-IP) Service Market Dynamics

2.3.1 Co-immunoprecipitation (Co-IP) Service Industry Trends

2.3.2 Co-immunoprecipitation (Co-IP) Service Market Drivers

2.3.3 Co-immunoprecipitation (Co-IP) Service Market Challenges

2.3.4 Co-immunoprecipitation (Co-IP) Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Co-immunoprecipitation (Co-IP) Service Players by Revenue

3.1.1 Global Top Co-immunoprecipitation (Co-IP) Service Players by Revenue (2020-2025)

3.1.2 Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Players (2020-2025)

3.2 Global Top Co-immunoprecipitation (Co-IP) Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Co-immunoprecipitation (Co-IP) Service Revenue

3.4 Global Co-immunoprecipitation (Co-IP) Service Market Concentration Ratio

3.4.1 Global Co-immunoprecipitation (Co-IP) Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Co-immunoprecipitation (Co-IP) Service Revenue in 2024

3.5 Global Key Players of Co-immunoprecipitation (Co-IP) Service Head office and Area Served

3.6 Global Key Players of Co-immunoprecipitation (Co-IP) Service, Product and Application

3.7 Global Key Players of Co-immunoprecipitation (Co-IP) Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Co-immunoprecipitation (Co-IP) Service Breakdown Data by Type

4.1 Global Co-immunoprecipitation (Co-IP) Service Historic Market Size by Type (2020-2025)

4.2 Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Type (2026-2031)

5 Co-immunoprecipitation (Co-IP) Service Breakdown Data by Application

5.1 Global Co-immunoprecipitation (Co-IP) Service Historic Market Size by Application (2020-2025)

5.2 Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)

6.2 North America Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)

6.4 North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)

7.2 Europe Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)

7.4 Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)

8.2 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)

9.2 Latin America Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)

9.4 Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)

10.2 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Creative Proteomics

11.1.1 Creative Proteomics Company Details

11.1.2 Creative Proteomics Business Overview

11.1.3 Creative Proteomics Co-immunoprecipitation (Co-IP) Service Introduction

11.1.4 Creative Proteomics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.1.5 Creative Proteomics Recent Development

11.2 Lifeasible

11.2.1 Lifeasible Company Details

11.2.2 Lifeasible Business Overview

11.2.3 Lifeasible Co-immunoprecipitation (Co-IP) Service Introduction

11.2.4 Lifeasible Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.2.5 Lifeasible Recent Development

11.3 ThermoFisher Scientific

11.3.1 ThermoFisher Scientific Company Details

11.3.2 ThermoFisher Scientific Business Overview

11.3.3 ThermoFisher Scientific Co-immunoprecipitation (Co-IP) Service Introduction

11.3.4 ThermoFisher Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.3.5 ThermoFisher Scientific Recent Development

11.4 Profacgen

11.4.1 Profacgen Company Details

11.4.2 Profacgen Business Overview

11.4.3 Profacgen Co-immunoprecipitation (Co-IP) Service Introduction

11.4.4 Profacgen Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.4.5 Profacgen Recent Development

11.5 Creative BioMart

11.5.1 Creative BioMart Company Details

11.5.2 Creative BioMart Business Overview

11.5.3 Creative BioMart Co-immunoprecipitation (Co-IP) Service Introduction

11.5.4 Creative BioMart Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.5.5 Creative BioMart Recent Development

11.6 Biologics International Corp

11.6.1 Biologics International Corp Company Details

11.6.2 Biologics International Corp Business Overview

11.6.3 Biologics International Corp Co-immunoprecipitation (Co-IP) Service Introduction

11.6.4 Biologics International Corp Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.6.5 Biologics International Corp Recent Development

11.7 Creative Diagnostics

11.7.1 Creative Diagnostics Company Details

11.7.2 Creative Diagnostics Business Overview

11.7.3 Creative Diagnostics Co-immunoprecipitation (Co-IP) Service Introduction

11.7.4 Creative Diagnostics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.7.5 Creative Diagnostics Recent Development

11.8 CD BioSciences

11.8.1 CD BioSciences Company Details

11.8.2 CD BioSciences Business Overview

11.8.3 CD BioSciences Co-immunoprecipitation (Co-IP) Service Introduction

11.8.4 CD BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.8.5 CD BioSciences Recent Development

11.9 Beijing Abace Biology

11.9.1 Beijing Abace Biology Company Details

11.9.2 Beijing Abace Biology Business Overview

11.9.3 Beijing Abace Biology Co-immunoprecipitation (Co-IP) Service Introduction

11.9.4 Beijing Abace Biology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.9.5 Beijing Abace Biology Recent Development

11.10 Nanjing Detai Bioengineering

11.10.1 Nanjing Detai Bioengineering Company Details

11.10.2 Nanjing Detai Bioengineering Business Overview

11.10.3 Nanjing Detai Bioengineering Co-immunoprecipitation (Co-IP) Service Introduction

11.10.4 Nanjing Detai Bioengineering Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.10.5 Nanjing Detai Bioengineering Recent Development

11.11 Guangzhou Fitgene Biotechnology

11.11.1 Guangzhou Fitgene Biotechnology Company Details

11.11.2 Guangzhou Fitgene Biotechnology Business Overview

11.11.3 Guangzhou Fitgene Biotechnology Co-immunoprecipitation (Co-IP) Service Introduction

11.11.4 Guangzhou Fitgene Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.11.5 Guangzhou Fitgene Biotechnology Recent Development

11.12 Nanjing Zoonbio Biotechnology

11.12.1 Nanjing Zoonbio Biotechnology Company Details

11.12.2 Nanjing Zoonbio Biotechnology Business Overview

11.12.3 Nanjing Zoonbio Biotechnology Co-immunoprecipitation (Co-IP) Service Introduction

11.12.4 Nanjing Zoonbio Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.12.5 Nanjing Zoonbio Biotechnology Recent Development

11.13 Shanghai Beyotime Biotechnology

11.13.1 Shanghai Beyotime Biotechnology Company Details

11.13.2 Shanghai Beyotime Biotechnology Business Overview

11.13.3 Shanghai Beyotime Biotechnology Co-immunoprecipitation (Co-IP) Service Introduction

11.13.4 Shanghai Beyotime Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.13.5 Shanghai Beyotime Biotechnology Recent Development

11.14 Beijing Bio-Tech Pack Scientific

11.14.1 Beijing Bio-Tech Pack Scientific Company Details

11.14.2 Beijing Bio-Tech Pack Scientific Business Overview

11.14.3 Beijing Bio-Tech Pack Scientific Co-immunoprecipitation (Co-IP) Service Introduction

11.14.4 Beijing Bio-Tech Pack Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.14.5 Beijing Bio-Tech Pack Scientific Recent Development

11.15 Wuhan Genecreate

11.15.1 Wuhan Genecreate Company Details

11.15.2 Wuhan Genecreate Business Overview

11.15.3 Wuhan Genecreate Co-immunoprecipitation (Co-IP) Service Introduction

11.15.4 Wuhan Genecreate Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.15.5 Wuhan Genecreate Recent Development

11.16 Wuhan Biorun BioSciences

11.16.1 Wuhan Biorun BioSciences Company Details

11.16.2 Wuhan Biorun BioSciences Business Overview

11.16.3 Wuhan Biorun BioSciences Co-immunoprecipitation (Co-IP) Service Introduction

11.16.4 Wuhan Biorun BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

11.16.5 Wuhan Biorun BioSciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Creative Proteomics

Lifeasible

ThermoFisher Scientific

Profacgen

Creative BioMart

Biologics International Corp

Creative Diagnostics

CD BioSciences

Beijing Abace Biology

Nanjing Detai Bioengineering

Nanjing Zoonbio Biotechnology

Shanghai Beyotime Biotechnology

Wuhan Biorun BioSciences

Guangzhou Fitgene Biotechnology

Beijing Bio-Tech Pack Scientific

Wuhan Genecreate

List of Tables

Table 1. Global Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tag Protein Immunoprecipitation

Table 3. Key Players of Non Tagged Protein Immunoprecipitation

Table 4. Key Players of Chromatin Immunoprecipitation

Table 5. Global Co-immunoprecipitation (Co-IP) Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Co-immunoprecipitation (Co-IP) Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Co-immunoprecipitation (Co-IP) Service Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Co-immunoprecipitation (Co-IP) Service Market Share by Region (2020-2025)

Table 9. Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Co-immunoprecipitation (Co-IP) Service Market Share by Region (2026-2031)

Table 11. Co-immunoprecipitation (Co-IP) Service Market Trends

Table 12. Co-immunoprecipitation (Co-IP) Service Market Drivers

Table 13. Co-immunoprecipitation (Co-IP) Service Market Challenges

Table 14. Co-immunoprecipitation (Co-IP) Service Market Restraints

Table 15. Global Co-immunoprecipitation (Co-IP) Service Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Co-immunoprecipitation (Co-IP) Service Market Share by Players (2020-2025)

Table 17. Global Top Co-immunoprecipitation (Co-IP) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-immunoprecipitation (Co-IP) Service as of 2024)

Table 18. Ranking of Global Top Co-immunoprecipitation (Co-IP) Service Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Co-immunoprecipitation (Co-IP) Service Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Co-immunoprecipitation (Co-IP) Service, Headquarters and Area Served

Table 21. Global Key Players of Co-immunoprecipitation (Co-IP) Service, Product and Application

Table 22. Global Key Players of Co-immunoprecipitation (Co-IP) Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Co-immunoprecipitation (Co-IP) Service Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Type (2020-2025)

Table 26. Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Type (2026-2031)

Table 28. Global Co-immunoprecipitation (Co-IP) Service Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Application (2020-2025)

Table 30. Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Application (2026-2031)

Table 32. North America Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)

Table 47. Creative Proteomics Company Details

Table 48. Creative Proteomics Business Overview

Table 49. Creative Proteomics Co-immunoprecipitation (Co-IP) Service Product

Table 50. Creative Proteomics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 51. Creative Proteomics Recent Development

Table 52. Lifeasible Company Details

Table 53. Lifeasible Business Overview

Table 54. Lifeasible Co-immunoprecipitation (Co-IP) Service Product

Table 55. Lifeasible Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 56. Lifeasible Recent Development

Table 57. ThermoFisher Scientific Company Details

Table 58. ThermoFisher Scientific Business Overview

Table 59. ThermoFisher Scientific Co-immunoprecipitation (Co-IP) Service Product

Table 60. ThermoFisher Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 61. ThermoFisher Scientific Recent Development

Table 62. Profacgen Company Details

Table 63. Profacgen Business Overview

Table 64. Profacgen Co-immunoprecipitation (Co-IP) Service Product

Table 65. Profacgen Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 66. Profacgen Recent Development

Table 67. Creative BioMart Company Details

Table 68. Creative BioMart Business Overview

Table 69. Creative BioMart Co-immunoprecipitation (Co-IP) Service Product

Table 70. Creative BioMart Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 71. Creative BioMart Recent Development

Table 72. Biologics International Corp Company Details

Table 73. Biologics International Corp Business Overview

Table 74. Biologics International Corp Co-immunoprecipitation (Co-IP) Service Product

Table 75. Biologics International Corp Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 76. Biologics International Corp Recent Development

Table 77. Creative Diagnostics Company Details

Table 78. Creative Diagnostics Business Overview

Table 79. Creative Diagnostics Co-immunoprecipitation (Co-IP) Service Product

Table 80. Creative Diagnostics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 81. Creative Diagnostics Recent Development

Table 82. CD BioSciences Company Details

Table 83. CD BioSciences Business Overview

Table 84. CD BioSciences Co-immunoprecipitation (Co-IP) Service Product

Table 85. CD BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 86. CD BioSciences Recent Development

Table 87. Beijing Abace Biology Company Details

Table 88. Beijing Abace Biology Business Overview

Table 89. Beijing Abace Biology Co-immunoprecipitation (Co-IP) Service Product

Table 90. Beijing Abace Biology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 91. Beijing Abace Biology Recent Development

Table 92. Nanjing Detai Bioengineering Company Details

Table 93. Nanjing Detai Bioengineering Business Overview

Table 94. Nanjing Detai Bioengineering Co-immunoprecipitation (Co-IP) Service Product

Table 95. Nanjing Detai Bioengineering Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 96. Nanjing Detai Bioengineering Recent Development

Table 97. Guangzhou Fitgene Biotechnology Company Details

Table 98. Guangzhou Fitgene Biotechnology Business Overview

Table 99. Guangzhou Fitgene Biotechnology Co-immunoprecipitation (Co-IP) Service Product

Table 100. Guangzhou Fitgene Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 101. Guangzhou Fitgene Biotechnology Recent Development

Table 102. Nanjing Zoonbio Biotechnology Company Details

Table 103. Nanjing Zoonbio Biotechnology Business Overview

Table 104. Nanjing Zoonbio Biotechnology Co-immunoprecipitation (Co-IP) Service Product

Table 105. Nanjing Zoonbio Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 106. Nanjing Zoonbio Biotechnology Recent Development

Table 107. Shanghai Beyotime Biotechnology Company Details

Table 108. Shanghai Beyotime Biotechnology Business Overview

Table 109. Shanghai Beyotime Biotechnology Co-immunoprecipitation (Co-IP) Service Product

Table 110. Shanghai Beyotime Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 111. Shanghai Beyotime Biotechnology Recent Development

Table 112. Beijing Bio-Tech Pack Scientific Company Details

Table 113. Beijing Bio-Tech Pack Scientific Business Overview

Table 114. Beijing Bio-Tech Pack Scientific Co-immunoprecipitation (Co-IP) Service Product

Table 115. Beijing Bio-Tech Pack Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 116. Beijing Bio-Tech Pack Scientific Recent Development

Table 117. Wuhan Genecreate Company Details

Table 118. Wuhan Genecreate Business Overview

Table 119. Wuhan Genecreate Co-immunoprecipitation (Co-IP) Service Product

Table 120. Wuhan Genecreate Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 121. Wuhan Genecreate Recent Development

Table 122. Wuhan Biorun BioSciences Company Details

Table 123. Wuhan Biorun BioSciences Business Overview

Table 124. Wuhan Biorun BioSciences Co-immunoprecipitation (Co-IP) Service Product

Table 125. Wuhan Biorun BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)

Table 126. Wuhan Biorun BioSciences Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

Table 130. Authors List of This Report

List of Figures

Figure 1. Co-immunoprecipitation (Co-IP) Service Picture

Figure 2. Global Co-immunoprecipitation (Co-IP) Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Co-immunoprecipitation (Co-IP) Service Market Share by Type: 2024 VS 2031

Figure 4. Tag Protein Immunoprecipitation Features

Figure 5. Non Tagged Protein Immunoprecipitation Features

Figure 6. Chromatin Immunoprecipitation Features

Figure 7. Global Co-immunoprecipitation (Co-IP) Service Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Co-immunoprecipitation (Co-IP) Service Market Share by Application: 2024 VS 2031

Figure 9. Drug Development Case Studies

Figure 10. Biomedical Research Case Studies

Figure 11. Co-immunoprecipitation (Co-IP) Service Report Years Considered

Figure 12. Global Co-immunoprecipitation (Co-IP) Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Co-immunoprecipitation (Co-IP) Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Co-immunoprecipitation (Co-IP) Service Market Share by Region: 2024 VS 2031

Figure 15. Global Co-immunoprecipitation (Co-IP) Service Market Share by Players in 2024

Figure 16. Global Co-immunoprecipitation (Co-IP) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Co-immunoprecipitation (Co-IP) Service Revenue in 2024

Figure 18. North America Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)

Figure 20. United States Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)

Figure 24. Germany Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Share by Region (2020-2031)

Figure 32. China Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)

Figure 40. Mexico Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)

Figure 44. Turkey Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Creative Proteomics Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 48. Lifeasible Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 49. ThermoFisher Scientific Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 50. Profacgen Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 51. Creative BioMart Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 52. Biologics International Corp Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 53. Creative Diagnostics Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 54. CD BioSciences Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 55. Beijing Abace Biology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 56. Nanjing Detai Bioengineering Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 57. Guangzhou Fitgene Biotechnology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 58. Nanjing Zoonbio Biotechnology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 59. Shanghai Beyotime Biotechnology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 60. Beijing Bio-Tech Pack Scientific Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 61. Wuhan Genecreate Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 62. Wuhan Biorun BioSciences Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions